Rise in number of research activities focused towards developing efficient biomarkers that can aid in early diagnosis of Alzheimer’s and Parkinson’s diseases is expected to drive the market growth.
Rise in number of research activities focused towards developing efficient biomarkers that can aid in early diagnosis of Alzheimer’s and Parkinson’s diseases is expected to drive the market growth.
Introduction of affordable biomarker testing, growing demand for non-invasive diagnostic techniques, and increasing adoption in clinical trials drive the growth of the market. However, strict government regulations and ethical concerns regarding early diagnosis restrict the market growth. On the other hand, increased demand for personalized medicines would create new opportunities for the market.
Neurological Biomarkers Market for Alzheimer’s and Parkinson’s Diseases - Global Opportunity Analysis and Industry Forecast, 2018-2025. The report presents detailed analyses of the key market trends, drivers & opportunities, market size & forecasts, top investment pockets, and competitive landscape. According to the report, the neurological biomarkers market for Alzheimer’s and Parkinson’s disease was valued at $3.95 billion in 2017, and is expected to reach $8.57 billion by 2025, registering a CAGR of 10.1% from 2018 to 2025.
Request for Sample Report for More Insights@ https://www.alliedmarketresearch.com/request-sample/3555
U.S. neurological Alzheimer’s disease biomarkers market to contribute highest revenue by 2025:-
The neurological Alzheimer’s disease biomarkers market in the U.S. contributed more than one-third of the global market revenue in in 2017, owing to significant increase in the number of educational institutes and rise in research & development activities. Asia-Pacific would grow at the fastest CAGR of 12.7% from 2018 to 2025, owing to rise in geriatric population who are suffer from Alzheimer’s disease in countries such as India and Japan.
China neurological Parkinson’s disease biomarkers market to grow the fastest through 2025:-
The neurological Parkinson’s disease biomarkers market in China would grow at the fastest CAGR of 10.1% from 2018 to 2025 due to the rise in the number of individuals diagnosed with Parkinson’s disease and implementation of pharmacological treatment and surgical intervention procedures. However, the U.S. contributed more than one-third of the total market share in 2017, owing to rise in prevalence of Parkinson’s disease among geriatric population in the region.
Frontrunners in the industry:-
- The leading market players analyzed in the report include
- Abbott Laboratories,
- Proteome Sciences,
- Myriad RBM,
- Athena Diagnostics,
- Thermo Fisher Scientific,
- Quanterix Corporation,
- Immunarray Pvt. Ltd.,
- Psynova Neurotech,
- Diagenic ASA,
- Bio-Rad Laboratories.
These market players have adopted strategies such as partnerships, collaborations, expansions, joint ventures, and others to strengthen their position in the industry.
Trending Reports of Healthcare:
Rapid Diagnostics Market - Global Opportunity Analysis and Industry Forecast, 2019-2028
Wound Retractor Market - Global Opportunity Analysis and Industry Forecast, 2019-2028
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch (dot) com